Farjah Algahtani: Joining the Global Conversation at ISTH 2026
Farjah Algahtani, Director of Epidemiology and Public Health Research at King Saud University, Professor Of Hematology, shared a post on LinkedIn:
“Excited to be at ISTH 2026 in Paris!
Honored to join colleagues, researchers, and healthcare professionals from around the world at the 34th Congress of the International Society on Thrombosis and Haemostasis (ISTH) in Paris.
The congress brings together more than 6,000 experts to share the latest advances in thrombosis, hemostasis, vascular biology, and patient care.
As someone passionate about clinical research and public health, I look forward to engaging in discussions that bridge scientific innovation with real-world practice.
From emerging therapies and evidence-based medicine to global collaboration, meetings like ISTH remind us that advancing patient outcomes requires not only groundbreaking science but also strong partnerships across disciplines and countries.
These conversations have the power to shape future research, improve healthcare delivery, and ultimately enhance the lives of patients affected by thrombotic and bleeding disorders.
Looking forward to connecting with colleagues, exchanging ideas, and contributing to meaningful collaborations throughout the congress.”

Stay updated with Hemostasis Today.
-
Nov 11, 2026, 15:42Tareq Abadl: The Clinical Impact of Kell Alloimmunization
-
Nov 11, 2026, 15:30Alejandro González Veliz: Does PCI Change The Long-Term Outcome In Stable Coronary Artery Disease?
-
Nov 11, 2026, 15:25Preparing for the SoHO Regulation – EBA Board Convenes in Vienna – European Blood Alliance
-
Nov 11, 2026, 15:20Vaidehi Prasanth: IV Iron in Heart Failure – Exploring Hospitalisation Benefits vs. Infection Risk in Open Heart
-
Nov 11, 2026, 15:18Stefan Prendić: Can Algorithms Support Antibody Identification in Immunohematology?
-
Nov 11, 2026, 15:12Perioperative Challenges in Hemophilia Patients on Rebalancing Therapies
-
Nov 11, 2026, 15:03Maria Elisa Mancuso: World-Renowned Faculty and 33 Global Participants Unite at Hemophilia Academy 2026
-
Nov 11, 2026, 15:01Hassan Raza: The JAK2 V617F Revolution
-
Nov 11, 2026, 14:57Edward Lee Carter: Factor Xla Inhibition Enters Clinical Practice – FDA Approval of Asundexian